Nancy Zhang has decent credentials, too, not anonymous.
Also, note I just got off the phone with Jason Napodano in the last couple minutes before the bell. Jason said he had read the article written by Biotech Sage and that the pricing of the scaffold that the author had done was incorrect because he did not understand how HUD works.
Also, the poster on Yahoo claiming that shorts were re-entering the stock at $3.40 was probably wrong. There were two sells in the last hour of around 10,000 to 20,000 block size, but in the last 5 minutes of trading I saw a block of 45,000 shares on the bid on level 2, within 2 cents of the current share price, that nobody wanted to touch. A short would have sold into that in order to sell high.